The prognostic value of C-reactive protein for children with pneumonia

Yuval Barak-Corren1,2, Yair Horovits1,2, Matti Erlichman1,2

  • 1Pediatric Department, Shaare Zedek Medical Center, Jerusalem, Israel.

Insights

C-reactive protein (CRP) effectively predicts pneumonia complications in children, aiding pediatricians in identifying high-risk patients for closer monitoring and improved outcomes.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Biochemistry
  • Infectious Diseases

Background:

  • Pneumonia is a common pediatric illness with potential for serious complications.
  • Accurate prognostic markers are crucial for timely and appropriate patient management.
  • C-reactive protein (CRP) is an inflammatory marker with potential prognostic value in pediatric pneumonia.

Purpose of the Study:

  • To evaluate the prognostic significance of C-reactive protein (CRP) levels.
  • To assess CRP's ability to predict pneumonia-associated complications in children.
  • To determine if CRP can aid in identifying children requiring closer follow-up.

Main Methods:

  • Retrospective cohort analysis of pediatric emergency department visits for pneumonia.
  • Inclusion criteria: discharge diagnosis of pneumonia, CRP measurement available, and non-viral pneumonia.
  • Outcomes assessed: hospitalization, parapneumonic effusion (PPE), chest drain placement, PICU admission, and bacteremia. Multivariate modeling and k-fold cross-validation were used.

Main Results:

  • Analysis included 810 pediatric pneumonia visits; 38.8% resulted in hospitalization, 2.2% in PICU admission.
  • 15.2% of cases developed parapneumonic effusion (PPE), with 28% requiring chest drain placement.
  • Elevated CRP levels showed a statistically significant association with all studied outcomes (P < .001).

Conclusions:

  • C-reactive protein (CRP) demonstrates significant prognostic value in pediatric pneumonia.
  • CRP can assist pediatricians in identifying patients at higher risk for complications.
  • Utilizing CRP may facilitate more targeted follow-up strategies for children with pneumonia.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
670
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
398
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
632
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
181
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
178